Latest & greatest articles for trazodone

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on trazodone or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on trazodone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for trazodone

1. Low-Dose Trazodone, Benzodiazepines, and Fall-Related Injuries in Nursing Homes: A Matched-Cohort Study

Low-Dose Trazodone, Benzodiazepines, and Fall-Related Injuries in Nursing Homes: A Matched-Cohort Study 30247773 2018 10 11 1532-5415 66 10 2018 Oct Journal of the American Geriatrics Society J Am Geriatr Soc Low-Dose Trazodone, Benzodiazepines, and Fall-Related Injuries in Nursing Homes: A Matched-Cohort Study. 1963-1971 10.1111/jgs.15519 To evaluate whether risk of fall-related injuries differs between nursing home (NH) residents newly dispensed low-dose trazodone and those newly dispensed (...) was 5.7% for low-dose trazodone users and 6.0% for benzodiazepine users (between-group change=-0.29, 95% confidence interval (CI)=-1.02-0.44]; hazard ratio=0.94, 95% CI=0.83-1.08). Findings were consistent across sensitivity analyses. New use of low-dose trazodone was no safer with respect to a risk of a fall-related injury than new use of benzodiazepines. Additional studies to compare the effectiveness and risks of low-dose trazodone with those of a variety of psychotropic drug therapies are required

EvidenceUpdates2018

2. Trazodone

Trazodone Top results for trazodone - Trip Database or use your Google+ account Liberating the literature My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for trazodone The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

3. Acute Liver Failure due to Trazodone and Diazepam

Acute Liver Failure due to Trazodone and Diazepam 28848778 2018 11 13 2341-4545 24 1 2017 Jan GE Portuguese journal of gastroenterology GE Port J Gastroenterol Acute Liver Failure due to Trazodone and Diazepam. 40-42 10.1159/000450878 Most antidepressant agents have the potential to cause liver injury, even at therapeutic doses. Nevertheless, drug-induced liver injury (DILI) from antidepressant agents is a rare event. There is no way to prevent idiopathic DILI, but the severity of the reaction (...) may be minimized with prompt recognition and early withdrawal of the agent. We describe a rare case of a 63-year-old man presenting with acute liver failure after 3 months of trazodone and diazepam administration at normal therapeutic doses, requiring liver transplantation. This report should increase physicians' awareness of this complication and call attention to the regular monitoring of liver tests in patients taking trazodone, in order to prevent life-threatening complications. Carvalhana

GE Portuguese journal of gastroenterology2016 Full Text: Link to full Text with Trip Pro

4. Trazodone

Trazodone USE OF TRAZODONE IN PREGNANCY 0344 892 0909 USE OF TRAZODONE IN PREGNANCY (Date of issue: March 2014 , Version: 2 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary Trazodone is a triazolopyridine antidepressant drug used in the treatment (...) of anxiety and depressive disorders, particularly where sedation is required. There is currently no evidence to suggest that exposure to trazodone is associated with an increased risk of congenital malformation, spontaneous abortion or stillbirth/intrauterine death, preterm delivery or low birth weight infants. However, data are limited to a very small number of exposed pregnant women and providing an estimate on the likelihood of adverse outcomes following exposure to trazodone in pregnancy

UK Teratology Information Service2014

5. Fluoxetine, trazodone and ritanserin are more effective than placebo when used as add-on therapies for negative symptoms of schizophrenia

Fluoxetine, trazodone and ritanserin are more effective than placebo when used as add-on therapies for negative symptoms of schizophrenia Fluoxetine, trazodone and ritanserin are more effective than placebo when used as add-on therapies for negative symptoms of schizophrenia | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Fluoxetine, trazodone and ritanserin are more effective than placebo when used as add-on therapies for negative symptoms of schizophrenia Article Text Therapeutics Fluoxetine, trazodone and ritanserin are more effective than

Evidence-Based Mental Health2011

6. Trazodone for agitation in dementia.

Trazodone for agitation in dementia. BACKGROUND: Behavioural and psychiatric disturbances affect at least 50% of people with Alzheimer's disease and other dementias. Neuroleptic drugs are extensively prescribed to treat behavioural manifestations of dementia in spite of only modest efficacy and a high frequency of adverse effects. There is clearly a need for safer and more effective remedies. Trazodone is a psychoactive compound with sedative and antidepressant properties, and with mixed (...) serotonin agonist and antagonist effects. Functional serotonergic deficits may be related to the genesis of behavioural disturbances in dementia. OBJECTIVES: To determine the clinical efficacy and safety of trazodone, for any type of behavioural or psychological cognition in people with dementia without an additional diagnosis of depression. SEARCH STRATEGY: Trials were identified from a search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 1 June 2004 using

Cochrane2004

7. Trazodone for erectile dysfunction: a systematic review and meta-analysis

Trazodone for erectile dysfunction: a systematic review and meta-analysis Trazodone for erectile dysfunction: a systematic review and meta-analysis Trazodone for erectile dysfunction: a systematic review and meta-analysis Fink H A, Macdonald R, Rutks I R, Wilt T J CRD summary This review assessed the efficacy and safety of trazodone for the treatment of erectile dysfunction. The authors' tentatively concluded that trazodone may be a helpful treatment for erectile dysfunction, particularly (...) at higher doses and in men with psychogenic erectile dysfunction. The authors discussed some of the limitations of the review and rightly advised caution when interpreting the findings. Authors' objectives To determine the efficacy and safety of trazodone for the treatment of erectile dysfunction (ED). Searching MEDLINE was searched from 1966 to the end of May 2002; the search terms were listed. The reference lists in identified reports and reviews were checked and abstracts from national AUA meetings

DARE.2003